Operating Expenses Summary of Marksans Pharma Limited

Marksans Pharma Limited's latest annual operating expenses in 2023 was 3.28 Billion INR , down -39.83% from previous year.
Marksans Pharma Limited's latest quarterly operating expenses in 2024 Q1 was 1.19 Billion INR , up 18.97% from previous quarter.
Marksans Pharma Limited reported a annual operating expenses of 6.43 Billion INR in annual operating expenses 2022, up 24.82% from previous year.
Marksans Pharma Limited reported a annual operating expenses of 5.15 Billion INR in annual operating expenses 2021, up 19.56% from previous year.
Marksans Pharma Limited reported a quarterly operating expenses of 1.82 Billion INR for 2023 Q2, up 7.78% from previous quarter.
Marksans Pharma Limited reported a quarterly operating expenses of 2.02 Billion INR for 2023 Q3, up 11.08% from previous quarter.

Annual Operating Expenses Chart of Marksans Pharma Limited (2023 - 2004)

Historical Annual Operating Expenses of Marksans Pharma Limited (2023 - 2004)

Year	Operating Expenses	Operating Expenses Growth
2023	3.28 Billion INR	-39.83%
2022	6.43 Billion INR	24.82%
2021	5.15 Billion INR	19.56%
2020	4.31 Billion INR	9.05%
2019	3.95 Billion INR	9.65%
2018	3.6 Billion INR	15.21%
2017	3.12 Billion INR	6.9%
2016	2.92 Billion INR	4.79%
2015	2.79 Billion INR	52.98%
2014	1.82 Billion INR	14.16%
2013	1.59 Billion INR	22.17%
2012	1.3 Billion INR	-50.42%
2011	2.64 Billion INR	271.7%
2010	710.39 Million INR	29.97%
2009	546.56 Million INR	4.85%
2008	521.31 Million INR	48.33%
2007	351.44 Million INR	29.2%
2006	272 Million INR	-0.67%
2005	273.85 Million INR	2.43%
2004	267.34 Million INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	1.19 Billion INR	18.97%
2023 Q2	1.82 Billion INR	7.78%
2023 Q3	2.02 Billion INR	11.08%
2023 Q1	1.68 Billion INR	15.31%
2023 FY	3.87 Billion INR	-39.83%
2023 Q4	1 Billion INR	-50.17%
2022 Q4	1.46 Billion INR	-16.95%
2022 Q2	1.63 Billion INR	3.78%
2022 FY	6.43 Billion INR	24.82%
2022 Q1	1.57 Billion INR	31.44%
2022 Q3	1.76 Billion INR	8.16%
2021 Q3	1.45 Billion INR	9.58%
2021 Q1	1.16 Billion INR	198.02%
2021 FY	5.15 Billion INR	19.56%
2021 Q2	1.33 Billion INR	13.96%
2021 Q4	1.19 Billion INR	-18.0%
2020 Q3	1.34 Billion INR	4.55%
2020 Q2	1.28 Billion INR	-0.15%
2020 Q1	1.28 Billion INR	29.43%
2020 FY	4.31 Billion INR	9.05%
2020 Q4	391.91 Million INR	-70.85%
2019 Q3	1.07 Billion INR	13.02%
2019 Q1	930.72 Million INR	19.7%
2019 Q4	995.28 Million INR	-7.46%
2019 Q2	951.57 Million INR	2.24%
2019 FY	3.95 Billion INR	9.65%
2018 Q4	777.57 Million INR	-12.65%
2018 Q3	890.18 Million INR	-16.26%
2018 Q2	1.06 Billion INR	18.32%
2018 FY	3.6 Billion INR	15.21%
2018 Q1	898.41 Million INR	14.03%
2017 FY	3.12 Billion INR	6.9%
2017 Q4	787.89 Million INR	-2.69%
2017 Q3	809.7 Million INR	1.2%
2017 Q2	800.1 Million INR	9.39%
2017 Q1	731.39 Million INR	2.32%
2016 Q3	779.42 Million INR	11.7%
2016 Q2	697.81 Million INR	-5.08%
2016 Q1	735.16 Million INR	-2.98%
2016 Q4	714.81 Million INR	-8.29%
2016 FY	2.92 Billion INR	4.79%
2015 Q2	733.22 Million INR	63.86%
2015 FY	2.79 Billion INR	52.98%
2015 Q3	854.98 Million INR	16.61%
2015 Q4	757.7 Million INR	-11.38%
2015 Q1	447.46 Million INR	-2.31%
2014 Q1	441.7 Million INR	17.96%
2014 Q4	458.05 Million INR	-3.37%
2014 Q3	474.01 Million INR	4.82%
2014 FY	1.82 Billion INR	14.16%
2014 Q2	452.2 Million INR	2.38%
2013 Q4	374.44 Million INR	-14.1%
2013 Q3	435.89 Million INR	2.26%
2013 Q1	388.71 Million INR	126.58%
2013 FY	1.59 Billion INR	22.17%
2013 Q2	426.26 Million INR	9.66%
2012 Q1	532.13 Million INR	0.0%
2012 FY	1.3 Billion INR	-50.42%
2012 Q4	171.55 Million INR	-47.98%
2012 Q3	329.78 Million INR	19.6%
2012 Q2	275.74 Million INR	-48.18%
2011 FY	2.64 Billion INR	271.7%
2010 FY	710.39 Million INR	29.97%
2009 FY	546.56 Million INR	4.85%
2008 FY	521.31 Million INR	48.33%
2007 FY	351.44 Million INR	29.2%
2006 FY	272 Million INR	-0.67%
2005 FY	273.85 Million INR	2.43%
2004 FY	267.34 Million INR	0.0%

Peer Operating Expenses Comparison of Marksans Pharma Limited

Name	Operating Expenses	Operating Expenses Difference
Abbott India Limited	5.98 Billion INR	45.05%
Cipla Limited	59.21 Billion INR	94.445%
Gland Pharma Limited	14.65 Billion INR	77.556%
GlaxoSmithKline Pharmaceuticals Limited	4.35 Billion INR	24.508%
Kopran Limited	1.41 Billion INR	-132.338%
NGL Fine-Chem Limited	1.75 Billion INR	-87.941%
Pfizer Limited	4.33 Billion INR	24.158%
Sanofi India Limited	4.13 Billion INR	20.391%
SMS Pharmaceuticals Limited	769.2 Million INR	-327.641%
TTK Healthcare Limited	3.72 Billion INR	11.606%

Global Stocks Search

Marksans Pharma Limited (MARKSANS.NS)

Operating Expenses Summary of Marksans Pharma Limited

Annual Operating Expenses Chart of Marksans Pharma Limited (2023 - 2004)

Historical Annual Operating Expenses of Marksans Pharma Limited (2023 - 2004)

Peer Operating Expenses Comparison of Marksans Pharma Limited